Cargando…

Findings of Gynecomastia That Developed in Follow-up Secondary to Bicalutamide Treatment on Bone Scan

Prostate cancer is a common neoplastic disease especially in elder patients. Metastatic prostate disease has low five-year survival rate. Bicalutamide is an androgen receptor antagonist that acts as an inhibitor by competizing androgen receptors in the target tissue and used as a treatment option in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ünal, Kemal, Gökçora, Nahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201428/
https://www.ncbi.nlm.nih.gov/pubmed/32368880
http://dx.doi.org/10.4274/mirt.galenos.2019.50490